BIO Digital 2020

We’re proud to participate in the BIO International Conference, which has transitioned into a new, virtual event format for 2020, BIO Digital. This year, we were selected as one of two Buzz of BIO winners. The conference runs from June 8-12, 2020.

Don’t miss our on-demand sessions:

Company presentation
Andy Holt, VP Business Development & Manufacturing

PANEL: The Role of New Technologies in Enabling Cell & Gene Therapies
BioProcess International Theater
A panel of experts will discuss product development and manufacturing challenges for cell and gene therapies and technologies that are being developed to address these challenges. Panelists include end users that can discuss the needs for new technologies, as well as technology providers.

The panel will discuss technologies for:
• Scalable and cost efficient production of viral vectors for gene therapy
• Non-viral approaches for gene therapy
• Scaling up to meet demand for autologous cell therapies

Chair: Doug Miller, Managing Director, BPTG
Panelists:
Daniella Kranjac, Co-Founder and Managing Director, Dynamk Capital
Tim Kelly, President, Manufacturing, RhiaPharmaceutical
Andy Ramelmeier, Executive Vice President, Technical Operations, Sangamo Therapeutics
Ran Zheng, Chief Technical Officer, Orchard Therapeutics